发明公开
EP2762160A1 Wt1 peptide cancer vaccine composition for mucosal administration
审中-公开
WT1-Peptid-Krebsimpfstoffzusammensetzung zur mukosalen Verabreichung
- 专利标题： Wt1 peptide cancer vaccine composition for mucosal administration
- 专利标题（中）： WT1-Peptid-Krebsimpfstoffzusammensetzung zur mukosalen Verabreichung
-
申请号： EP14000325.2申请日： 2014-01-29
-
公开(公告)号： EP2762160A1公开(公告)日： 2014-08-06
- 发明人: Asari, Daisuke , Matsushita, Kyohei , Okazaki, Arimichi , Maeda, Yoshiki , Okubo, Katsuyuki , Hori, Mitsuhiko , Sugiyama, Haruo
- 申请人： NITTO DENKO CORPORATION , OSAKA UNIVERSITY
- 申请人地址： 1-2, Shimohozumi 1-chome Ibaraki-shi, Osaka 567-8680 JP
- 专利权人： NITTO DENKO CORPORATION,OSAKA UNIVERSITY
- 当前专利权人： NITTO DENKO CORPORATION,OSAKA UNIVERSITY
- 当前专利权人地址： 1-2, Shimohozumi 1-chome Ibaraki-shi, Osaka 567-8680 JP
- 代理机构： Müller-Boré & Partner Patentanwälte PartG mbB
- 优先权： JP2013020904 20130205
- 主分类号： A61K39/00
- IPC分类号： A61K39/00
摘要：
The present invention provides a cancer vaccine composition for mucosal administration for inducing cellular immunity, comprising (i) a WT1 peptide and/or a modified WT1 peptide; and (ii) a cellular immunity induction promoter. The composition efficiently induces cellular immunity against a cancer in a subject.
信息查询
